tiprankstipranks
Relay Therapeutics, Elevar Therapeutics enter licensing agreement
PremiumThe FlyRelay Therapeutics, Elevar Therapeutics enter licensing agreement
1M ago
Relay Therapeutics price target raised to $20 from $19 at H.C. Wainwright
Premium
The Fly
Relay Therapeutics price target raised to $20 from $19 at H.C. Wainwright
2M ago
Relay Therapeutics Reports Q3 2024 Results and Advances
Premium
Company Announcements
Relay Therapeutics Reports Q3 2024 Results and Advances
2M ago
Relay Therapeutics price target raised to $19 from $18 at H.C. Wainwright
PremiumThe FlyRelay Therapeutics price target raised to $19 from $18 at H.C. Wainwright
4M ago
Relay Therapeutics 28.6M share Secondary priced at $7.00
Premium
The Fly
Relay Therapeutics 28.6M share Secondary priced at $7.00
4M ago
Oracle reports Q1 beat, EU says Apple must pay: Morning Buzz
Premium
The Fly
Oracle reports Q1 beat, EU says Apple must pay: Morning Buzz
4M ago
Relay Therapeutics upgraded to Buy from Hold at Jefferies
PremiumThe FlyRelay Therapeutics upgraded to Buy from Hold at Jefferies
4M ago
Relay Therapeutics downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Relay Therapeutics downgraded to Perform from Outperform at Oppenheimer
4M ago
Relay Therapeutics reinstated with a Buy at Goldman Sachs
Premium
The Fly
Relay Therapeutics reinstated with a Buy at Goldman Sachs
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100